iBIO NEWS
Your source for the news and events happening in our communityiBIO NEWS
GBG September Grant Opportunities for iBIO Members
iBIO Leads 74-Organization Coalition Urging Illinois Congressional Delegation to Reauthorize SBIR Program
G2G August Grant Report: 78 Non-Dilutive Funding Opportunities for iBIO Members
iBIO Releases Inaugural Member Investor Portfolio Report Showcasing $1.24 Billion in Illinois Life Sciences Investment
COMMUNITY NEWS
iBIO January Grants Report Highlights Expansive Funding Opportunities for Life Sciences Innovation
Xentria Secures Landmark Agreement with NYU for Cardiovascular Therapy Development
Capital Pulse: Flow Medical Secures $5M Seed Round, Including First-Ever UCM Ventures Investment
The Growing Crisis of Antimicrobial Resistance: Meitheal Takes Action with XENLETA®
POLICY NEWS
IBIO Statement on Industry Tariffs
iBIO Joins AdvaMed Coalition Pushing for Faster Medicare Coverage of Medical Devices
iBIO Leads 74-Organization Coalition Urging Illinois Congressional Delegation to Reauthorize SBIR Program
Illinois Life Sciences Companies Urged to Sign Group Letter Supporting SBIR/STTR Reauthorization
Illinois companies stand to lose $90 million in annual funding if federal programs expire September 30th Illinois life sciences companies and associations have until August 15th to sign onto a group letter urging the state’s Congressional Delegation to reauthorize the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs before their September […]
ALL NEWS
iBIO Announces 2025 iCON Awards Winners Honoring Illinois Life Sciences Leaders
iBIO (Illinois Biotechnology Innovation Organization) is proud to announce the winners of the...
Setting the Record Straight on 340B in Illinois
There’s been a lot of misinformation circulating about the 340B Drug Pricing Program and HB2371 in...
IBIO Statement on Industry Tariffs
John Conrad, President and CEO of the Illinois Biotechnology Innovation Organization (iBIO) issued...
GBG September Grant Opportunities for iBIO Members
G2G Consulting has released the September Government Bioscience Grants (GBG) report for iBIO...
iBIO Joins AdvaMed Coalition Pushing for Faster Medicare Coverage of Medical Devices
iBIO has joined AdvaMed and 65 other organizations in urging the Centers for Medicare and Medicaid...
iBIO Leads 74-Organization Coalition Urging Illinois Congressional Delegation to Reauthorize SBIR Program
The Illinois Biotechnology Innovation Organization (iBIO) delivered a coalition lettercoalition...
G2G August Grant Report: 78 Non-Dilutive Funding Opportunities for iBIO Members
The latest Government Bioscience Grants (GBG) report from G2G Consulting identifies 78...
iBIO Releases Inaugural Member Investor Portfolio Report Showcasing $1.24 Billion in Illinois Life Sciences Investment
Report highlights nearly 100 life science companies and investment trends as Chicago prepares to...
Illinois Life Sciences Companies Urged to Sign Group Letter Supporting SBIR/STTR Reauthorization
Illinois companies stand to lose $90 million in annual funding if federal programs expire September 30th Illinois life sciences companies and associations have until August 15th to sign onto a group letter urging the state’s Congressional Delegation to reauthorize the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs before their September […]
ClostraBio’s Next-Gen Probiotic Clears Safety Hurdle
Chicago biotech startup ClostraBio has secured GRAS (Generally Recognized as Safe) status for its...